UDG Healthcare
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of UDG Healthcare generated cash of $230,656,000, which is more than the previous year. Cash used in financing activities reached the amount of -$21,031,000 last year. Net change in cash is therefore $110,817,000.
Cash Flow
| 2011 | 70.32M | -55.33M | -79.50M |
|---|---|---|---|
| 2012 | 99.61M | -194.57M | 43.96M |
| 2013 | 104.63M | -104.24M | 142.04M |
| 2014 | 80.81M | -50.64M | -59.21M |
| 2015 | 154.60M | -76.56M | -24.25M |
| 2016 | 75.00M | 336.38M | -203.47M |
| 2017 | 107.77M | -262.86M | -91.37M |
| 2018 | 102.51M | -76.32M | -33.06M |
| 2019 | 129.25M | -130.65M | -39.08M |
| 2020 | 230.65M | -105.24M | -21.03M |
UDG.L Cash Flow Statement (2011 – 2020)
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 135.22M | 180.09M | 187.46M | 428.72M | 240.17M | 176.94M | 219.68M | 95.59M | 139.00M | 225.88M |
Operating activities | ||||||||||
Net income | 92.82M | 57.45M | 3.79M | 71.85M | 216.82M | 61.71M | 140.06M | 38.21M | 61.24M | 49.46M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 81.71M | 63.54M | 61.51M | 46.67M | 38.62M | 48.08M | 45.45M | 45.24M | 37.66M | 39.95M |
Stock-based compensation expense | 5.59M | 4.4M | 5.06M | 3.61M | 2.20M | 2.00M | 2.21M | 515.47K | 983.55K | 1.56M |
| Deferred income tax benefit | 5.59M | 4.4M | 5.06M | 3.61M | 2.20M | 2.00M | 2.21M | 515.47K | 983.55K | 1.56M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | -2.69M | -6.98M | 4.52M | 1.89M | 3.48M | -4.20M | -1.97M | -10.40M | -14.43M | 2.81M |
Accounts payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | 230.65M | 129.25M | 102.51M | 107.77M | 75.00M | 154.60M | 80.81M | 104.63M | 99.61M | 70.32M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -37.9M | -39.49M | -60.62M | -51.35M | -43.08M | -72.76M | -48.37M | -72.01M | -81.36M | -23.09M |
Acquisitions Net | -68.37M | -94.22M | -18.34M | -212.70M | 408.79M | -5.01M | -15.75M | -40.38M | -119.11M | -38.14M |
Cash generated by investing activities | -105.24M | -130.65M | -76.32M | -262.86M | 336.38M | -76.56M | -50.64M | -104.24M | -194.57M | -55.33M |
Financing activities | ||||||||||
Common Stock Issued | 813K | 1.17M | 1.36M | 3.17M | 4.50M | 5.76M | 2.81M | 5.13M | 2.21M | 5.47M |
Payments for dividends | -42.08M | -40.32M | -34.70M | -31.27M | -30.72M | -28.29M | -29.54M | -29.78M | -26.76M | -23.88M |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | -7 | -7 | 0 | -1.33M | -14.21M |
Repayments of term debt | -63.40M | 0 | -2.11M | 0 | -177.17M | 0 | -131.35M | -47.49M | -256.80K | -46.24M |
Cash used in financing activities | -21.03M | -39.08M | -33.06M | -91.37M | -203.47M | -24.25M | -59.21M | 142.04M | 43.96M | -79.50M |
Net Change In Cash | 110.81M | -44.87M | -7.37M | -241.26M | 190.77M | 63.93M | -20.14M | 138.03M | -48.04M | -65.13M |
Cash at end of period | 246.04M | 135.22M | 180.09M | 187.46M | 430.94M | 240.88M | 199.54M | 233.62M | 90.96M | 160.75M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |